• Profile
Close

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: Real-world study of 18 million patients in four European cohorts

BMC Medicine May 24, 2019

Alexander M, et al. - In this investigation, researchers assessed over 18 million adult healthcare records to estimate the risk of acquiring advanced diagnoses of liver disease in non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) patients vs individually matched controls. Out of 18,782,281 adults, a total of 136,703 with coded NAFLD/NASH were identified. Coded patients with NAFLD/NASH were more likely than matched controls to have diabetes, hypertension, and obesity. Baseline diagnosis of diabetes was the strongest independent predictor of a diagnosis of hepatocellular carcinoma or cirrhosis. According to real-world population data, recorded NAFLD/NASH diagnosis may increase the risk of life-threatening liver outcomes.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay